INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2016

Pharmacotherapies and food components like thylakoids show potential for targeting reward-induced eating and food cravings.

This narrative review examines appetite and reward-induced eating behavior, noting that cravings triggered by food cues activate mesocorticolimbic dopamine pathways and affect weight outcomes. Approved weight-management medications, including naltrexone-bupropion, lorcaserin, liraglutide, and phentermine, show promise or preliminary efficacy in targeting craving-related eating behavior. Additionally, food components such as thylakoid membranes have been shown to influence food cravings.

Study type
Narrative review
Who was studied
Individuals with reward-induced eating and food cravings
What was measured
Effects of pharmacological agents and food components on food cravings

THE PAPER

Reward-Induced Eating: Therapeutic Approaches to Addressing Food Cravings.

Rebello CJ, Greenway FL. Adv Ther, 2016.

PubMed 27718159 ↗DOI 10.1016/j.appet.2014.06.101 ↗

Weight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.